Alignment Healthcare, Inc. (ALHC) Balance Sheet

The equity recovery appears to reflect a return to positive earnings in several recent quarters rather than external capital, though the 2026Q3 ROE of -3.0% shows the rebuild is uneven. Liabilities have grown in step with membership, meaning the growth in equity is being partly absorbed by larger medical obligations. Investors should monitor whether equity growth can keep pace with liability expansion if utilization rises.

The steady loss ratio alongside rising reserves suggests reserving has kept pace with the medical cost base, though the reported figures do not isolate IBNR adequacy or prior-period development. A combined ratio above 100% in several recent quarters indicates little cushion for adverse development. Reserve estimates warrant further investigation given the sensitivity of quarterly earnings to claim timing.

Equity-to-liabilities of roughly 0.27 leaves limited absorptive capacity if medical cost trends deteriorate, particularly given recent quarters of net losses. Statutory capital adequacy cannot be assessed from the supplied data, so the regulatory buffer remains unverified. Investors should monitor future equity build against membership growth to judge whether capital can support continued expansion.

Without disclosed cash or liquid investment figures, the claims-paying liquidity profile cannot be measured against expected medical payouts. Operating cash flow swings between positive and negative quarters suggest timing effects in premium and claims settlement may affect near-term liquidity. Investors should track cash disclosures to confirm coverage of claims obligations.